TY - STD TI - Garrett-Mayer E. The continual reassessment method for dose-finding studies: a tutorial. Clin Trials. 2006;3:57. ID - ref1 ER - TY - JOUR AU - Goodman, S. N. AU - Zahurak, M. L. AU - Piantadosi, S. PY - 1995 DA - 1995// TI - Some practical improvements in the continual reassessment method for phase I studies JO - Stat Med VL - 14 UR - https://doi.org/10.1002/sim.4780141102 DO - 10.1002/sim.4780141102 ID - Goodman1995 ER - TY - JOUR AU - Yeatts, S. D. PY - 2013 DA - 2013// TI - Novel methodologic approaches to phase I, II, and III trials JO - Stroke VL - 44 UR - https://doi.org/10.1161/STROKEAHA.111.000031 DO - 10.1161/STROKEAHA.111.000031 ID - Yeatts2013 ER - TY - JOUR AU - O’Quigley, J. PY - 1999 DA - 1999// TI - Another look at two phase I clinical trial designs JO - Stat Med VL - 18 UR - https://doi.org/3.0.CO;2-Z DO - 3.0.CO;2-Z ID - O’Quigley1999 ER - TY - JOUR AU - Iasonos, A. AU - Wilton, A. S. AU - Riedel, E. R. AU - Seshan, V. E. AU - Spriggs, D. R. PY - 2008 DA - 2008// TI - A comprehensive comparison of the continual reassessment method to the standard 3 + 3 dose escalation scheme in phase I dose-finding studies JO - Clin Trials VL - 5 UR - https://doi.org/10.1177/1740774508096474 DO - 10.1177/1740774508096474 ID - Iasonos2008 ER - TY - JOUR AU - O’Quigley, J. AU - Chevret, S. PY - 1991 DA - 1991// TI - Methods for dose finding studies in cancer clinical trials: a review and results of a Monte Carlo study JO - Stat Med VL - 10 UR - https://doi.org/10.1002/sim.4780101104 DO - 10.1002/sim.4780101104 ID - O’Quigley1991 ER - TY - JOUR AU - Tourneau, C. AU - Lee, J. J. AU - Siu, L. L. PY - 2009 DA - 2009// TI - Dose escalation methods in phase I cancer clinical trials JO - J Natl Cancer Inst VL - 101 UR - https://doi.org/10.1093/jnci/djp079 DO - 10.1093/jnci/djp079 ID - Tourneau2009 ER - TY - JOUR AU - Rogatko, A. AU - Schoeneck, D. AU - Jonas, W. AU - Tighiouart, M. AU - Khuri, F. R. AU - Porter, A. PY - 2007 DA - 2007// TI - Translation of innovative designs into phase I trials JO - J Clin Oncol VL - 25 UR - https://doi.org/10.1200/JCO.2007.12.1012 DO - 10.1200/JCO.2007.12.1012 ID - Rogatko2007 ER - TY - JOUR AU - Lee, S. M. AU - Cheung, Y. K. PY - 2009 DA - 2009// TI - Model calibration in the continual reassessment method JO - Clin Trials VL - 6 UR - https://doi.org/10.1177/1740774509105076 DO - 10.1177/1740774509105076 ID - Lee2009 ER - TY - JOUR AU - Iasonos, A. AU - O’Quigley, J. PY - 2011 DA - 2011// TI - Continual reassessment and related designs in dose-finding studies JO - Stat Med VL - 30 UR - https://doi.org/10.1002/sim.4215 DO - 10.1002/sim.4215 ID - Iasonos2011 ER - TY - JOUR AU - Chevret, S. PY - 1993 DA - 1993// TI - The continual reassessment method in cancer phase I clinical trials: a simulation study JO - Stat Med VL - 12 UR - https://doi.org/10.1002/sim.4780121201 DO - 10.1002/sim.4780121201 ID - Chevret1993 ER - TY - JOUR AU - Jaki, T. AU - Clive, S. AU - Weir, C. J. PY - 2013 DA - 2013// TI - Principles of dose finding studies in cancer: a comparison of trial designs JO - Cancer Chemother Pharmacol VL - 71 UR - https://doi.org/10.1007/s00280-012-2059-8 DO - 10.1007/s00280-012-2059-8 ID - Jaki2013 ER - TY - JOUR AU - Yin, G. AU - Yuan, Y. PY - 2009 DA - 2009// TI - Bayesian model averaging continual reassessment method in phase I clinical trials JO - J Am Stat Assoc VL - 104 UR - https://doi.org/10.1198/jasa.2009.ap08425 DO - 10.1198/jasa.2009.ap08425 ID - Yin2009 ER - TY - STD TI - Iasonos A, O’Quigley J. Interplay of priors and skeletons in two-stage continual reassessment method. Stats Med. 2012. https://doi.org/10.1002/sim.5559. ID - ref14 ER - TY - JOUR AU - James, G. D. AU - Symeonides, S. AU - Marshall, J. AU - Young, J. AU - Clack, G. PY - 2016 DA - 2016// TI - Continual reassessment method for dose escalation clinical trials in oncology: a comparison of prior skeleton approaches using AZD3514 data JO - BMC Cancer VL - 16 UR - https://doi.org/10.1186/s12885-016-2702-6 DO - 10.1186/s12885-016-2702-6 ID - James2016 ER - TY - STD TI - PSI annual conference 2015.https://www.psiweb.org/docs/default-source/default-document-library/programme-of-abstracts.pdf?sfvrsn=0. Accessed 3 Dec 2020. UR - https://www.psiweb.org/docs/default-source/default-document-library/programme-of-abstracts.pdf?sfvrsn=0 ID - ref16 ER - TY - STD TI - PSI annual conference 2016. https://psiweb.org/docs/default-source/default-document-library/16psiber-programme-of-abstracts-v2.pdf?sfvrsn=0. Accessed 3 Dec 2020. UR - https://psiweb.org/docs/default-source/default-document-library/16psiber-programme-of-abstracts-v2.pdf?sfvrsn=0 ID - ref17 ER - TY - CHAP AU - He, W. AU - Liu, J. PY - 2014 DA - 2014// TI - Methods and applications of statistics in clinical trials BT - Concepts, principles, trials, and designs PB - Sons, Ltd CY - Hoboken ID - He2014 ER - TY - JOUR AU - Wheeler, G. M. AU - Sweeting, M. J. AU - Mander, A. P. PY - 2016 DA - 2016// TI - AplusB: A Web Application for Investigating A + B Designs for Phase I Cancer Clinical Trials JO - PLoS ONE VL - 11 UR - https://doi.org/10.1371/journal.pone.0159026 DO - 10.1371/journal.pone.0159026 ID - Wheeler2016 ER - TY - STD TI - EAST Statistical software for the design, simulation and monitoring clinical trials. Cambridge: Cytel Inc. ID - ref20 ER - TY - STD TI - Pei-Ling C, Yong L, Weichung JS. 2008. Unifying CRM and EWOC designs for phase I cancer clinical trials. J Statist Plan Infer 2009;139:1146–1163. ID - ref21 ER - TY - JOUR AU - O’Quigley, J. AU - Pepe, M. AU - Fisher, L. PY - 1990 DA - 1990// TI - Continual reassessment method: a practical design for phase 1 clinical trials in cancer JO - Biometrics VL - 46 UR - https://doi.org/10.2307/2531628 DO - 10.2307/2531628 ID - O’Quigley1990 ER - TY - JOUR AU - Haitao, P. AU - Yuan, Y. PY - 2017 DA - 2017// TI - A default method to specify skeletons for Bayesian model averaging continual reassessment method for phase I clinical trials JO - Stat Med VL - 36 UR - https://doi.org/10.1002/sim.6941 DO - 10.1002/sim.6941 ID - Haitao2017 ER -